Mirtazapine, sold under the brand name Remeron among others, is an antidepressant of the atypical antidepressants class primarily used to treat depression. Its full effect may take more than four weeks to occur, with some benefit possibly as early as one to two weeks
Anant Labs manufacture and furnish high quality Mirtazapine impurities for global markets. Our Mirtazapine EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Synonyms
1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c][2]benzazepinemirtazapine85650-52-8RemeronMepirzepine6-AzamianserinRemergonZispinPromyrtilRemergilRexerAvanzaNorsetRemeron SolTabMirtazapinaORG 3770Mirtazapinum2-Methyl-1,2,3,4,10,14b-hexahydropyrazino[2,1-a]pyrido[2,3-c][2]benzazepineOrg-3770MiratazMirtazapinMirtazapine anhydrousMepirzapineDTXSID00233251,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepineA051Q2099QOrg3770Pyrazino(2,1-a)pyrido(2,3-c)(2)benzazepine, 1,2,3,4,10,14b-hexahydro-2-methyl-CHEBI:6950DTXCID5033255-methyl-2,5,19-triazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(15),8,10,12,16,18-hexaenePyrazino[2,1-a]pyrido[2,3-c][2]benzazepine, 1,2,3,4,10,14b-hexahydro-2-methyl-5-methyl-2,5,19-triazatetracyclo[13.4.0.0^{2,7}.0^{8,13}]nonadeca-1(19),8(13),9,11,15,17-hexaeneRemeronsoltab6 Azamianserin1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c]benzazepine2-methyl-1,2,3,4,10,14b-hexahydropyrazino(2,1-a)pyrido(2,3-c)(2)benzazepine5-methyl-2,5,19-triazatetracyclo(13.4.0.0^(2,7).0^(8,13))nonadeca-1(19),8(13),9,11,15,17-hexaene5-methyl-2,5,19-triazatetracyclo(13.4.0.02,7.08,13)nonadeca-1(15),8,10,12,16,18-hexaeneRefChem:55652N06AX1161337-67-5MirtazepineMepirzapinMirtazipineMirtazapinum [INN-Latin]Mirtazapina [INN-Spanish]MFCD008654272-methyl-1,2,3,4,10,14b-hexahydrobenzo[c]pyrazino[1,2-a]pyrido[3,2-f]azepineCHEMBL654Mirtazapine (Remeron, Avanza)(S)-Org3770;(S)-6-AzamianserinNCGC00025346-02(14bR)-2-methyl-1,2,3,4,10,14b-hexahydropyrazino[2,1-a]pyrido[2,3-c][2]benzazepineAzamianserinMirtazapine [USAN:BAN:INN]Smilon2-methyl-1,2,3,4,9,13b-hexahydro-2,4a,5-triaza-tribenzo[a,c,e]cyclohepteneDiosmetin 3',7-Bis(2,3,4-tri-O-acetyl-D-glucuronic Acid Methyl Ester)159355-60-9SMR000466347Remeron (TN)SR-01000597530EINECS 288-060-6Mirtazapine CRSUNII-A051Q2099Q(R)-Org3770;(R)-6-Azamianserin6-Aza-mianserin1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c](2)benzazepineMirtazapine [USAN:USP:INN:BAN]Reflex (TN)(1)-1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)(2)benzazepineME-2040Mirtazapine (Standard)MIRTAZAPINE [MI]MIRTAZAPINE [INN]MIRTAZAPINE [JAN]MIRTAZAPINE [USAN]MIRTAZAPINE [VANDF]SCHEMBL35408MIRTAZAPINE [USP-RS]MIRTAZAPINE [WHO-DD]MLS000759460MLS001076676MLS001424294MLS006011449orb322593Mirtazapine (JAN/USP/INN)GTPL7241orb1310902orb3141190Mirtazapine - Bio-X trade markMIRTAZAPINE [GREEN BOOK]SCHEMBL29484433HY-B0352RMIRTAZAPINE, (+/-)-Mirtazapine, >=98% (HPLC)Mirtazapine, 1mg/ml in MethanolMIRTAZAPINE [ORANGE BOOK]HMS2052H03HMS2233K03HMS3268F21HMS3370B05HMS3374J01HMS3394H03HMS3413C11HMS3657M13HMS3677C11HMS3713P13HMS3884O18HMS5080H15MIRTAZAPINE [EP MONOGRAPH]MIRTAZAPINE [USP MONOGRAPH]PS11 - Mirtazapine/NormirtazapineHY-B0352Mirtazapine 1.0 mg/ml in MethanolMSK10500Tox21_110965BBL009962BDBM50115644EBC-08263PDSP1_001529PDSP2_001513s2016STK711107AKOS005530681CCG-101154CCG-220556DB00370FM26014KS-1086NC00404NCGC00025346-01NCGC00025346-08AC-15480BM164672SY002095CAS-61337-67-5M2151NS00009441SW197784-4T0137EN300-49851C07570D00563AB00698265_08L001294Q421930SR-01000597530-1SR-01000597530-4BRD-A64977602-001-01-9BRD-A64977602-001-04-3BRD-A64977602-001-13-4BRD-A64977602-001-14-2BRD-A64977602-001-15-9Z905065772Mirtazapine, European Pharmacopoeia (EP) Reference StandardMirtazapine, United States Pharmacopeia (USP) Reference Standard(+/-)-12-Methyl-1,2,3,4,9,13b-hexahydro-2,4a,5-triaza-tribenzo[a,c,e]cycloheptene1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c][2]-benzazepineMirtazapine for system suitability, European Pharmacopoeia (EP) Reference Standard5-methyl-2,5,19-triazatetracyclo[13.4.0.0?,?.0?,??]nonadeca-1(15),8,10,12,16,18-hexaene5-methyl-2,5,19-triazatetracyclo[13.4.0.0^{2,7}.0^{8,13}]nonadeca-1(19),8,10,12,15,17-hexaenePyrazino[2,1-a]pyrido[2,3-c][2]benzazepine, 1,2,3,4,10,14b-hexahydro-2-methyl-, (.+/-.)-
